More than 50 biotech leaders and investors are urging the FDA to disregard a methodologically flawed report on mifepristone.

WEDNESDAY, July 16, 2025 (HealthDay News) — A federal appeals court has ruled that West Virginia can limit access to ...

Good news for activists after Trump administration disappointments. "For us to once again federalize the issue of abortion without a clear directive from Congress, right on the heels of Dobbs, would ...

West Virginia enacted a law prohibiting abortion in most circumstances shortly following the Dobbs decision in 2022.

In this powerful statement, a Democratic lawmaker denounces the Trump administration’s escalating efforts to ban abortion nationwide—this time by targeting the widely used, FDA-approved drug ...

A recent appellate decision that allowed West Virginia to block access to the abortion-inducing drug mifepristone is fueling ...

But the West Virginia abortion-pills case, GenBioPro v. Raynes, drew 10 friend-of-the-court briefs supporting the ...

A divided federal appeals court panel on Tuesday upheld West Virginia’s ban on medication abortion, ruling that the law does not conflict with the Food and Drug Administration’s (FDA) ability to ...

A federal appeals court on Tuesday upheld a lower court’s decision to restrict abortion pill sales in West Virginia. A ...

Earlier, in January 2025, the FDA released a companion piece of draft guidance titled “Considerations for the Use of ...

Presented by AstraZeneca{beacon} Health Care Health Care   The Big Story FDA reverses course on Juul The Food and Drug Administration is allowing Juul Labs to keep its electronic ...

Trump's DOJ has issued a new legal opinion barring federal funds from being used for transportation and other "ancillary ...